Factors associated with diabetic macular edema in patients with proliferative diabetic retinopathy

被引:2
|
作者
O'Fee, John R. [1 ]
Juliano, Joseph [1 ]
Moshfeghi, Andrew A. [1 ]
机构
[1] Univ Southern Calif, Keck Sch Med, USC Roski Eye Inst, Dept Ophthalmol, 1450 San Pablo St,Suite 4703, Los Angeles, CA 90033 USA
关键词
Diabetes; Proliferative diabetic retinopathy; Diabetic macular edema; Vitreoretinal interface; ENDOTHELIAL GROWTH-FACTOR; POSTERIOR VITREOUS DETACHMENT; VITRECTOMY; PERSISTENT; RECEPTORS; OUTCOMES;
D O I
10.1007/s00417-022-05595-9
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To identify factors associated with diabetic macular edema (DME) and to characterize the types of DME present in eyes with proliferative diabetic retinopathy (PDR). Methods Observational, retrospective case series of PDR patients reviewed for demographic information, general medical history, ophthalmologic history, optical coherence tomography (OCT), and fluorescein angiogram image characteristics. DME and vitreomacular interface (VMI) status were determined using OCT images. DME was defined as center-involving DME (CI-DME) and noncenter-involving DME (NCI-DME). VMI was defined as vitreomacular adhesion (VMA), vitreomacular traction (VMT), or macular posterior vitreous detachment (PVD). Results A total of 293 eyes of 210 screened patients with PDR were included. Of the eyes, 194/293 (66.2%) had DME, and 99/293 (33.8%) had no DME; in univariable analysis, there were no significant differences in VMI status (p = 0.4) or epiretinal membrane (ERM, p = 0.1) between them. Of 194 eyes with DME, 90/194 (46.4%) had CI-DME, and 104/194 (53.6%) had NCI-DME. In univariable analysis, CI-DME eyes were significantly more likely than NCI-DME eyes to have a PVD (p = 0.029) and ERM (p < 0.001). In multivariable analysis, the presence of younger age (p = 0.028) and presence of ERM (p = 0.001) were significantly more likely to be observed in eyes with CI-DME. Conclusion In this exploratory study focused on diabetic patients with PDR, we determined that VMI status did not have a significant association with DME in general, but VMI status, younger age, and presence of ERM may be associated with CI-DME.
引用
收藏
页码:2191 / 2200
页数:10
相关论文
共 50 条
  • [1] Factors associated with diabetic macular edema in patients with proliferative diabetic retinopathy
    John R. O’Fee
    Joseph Juliano
    Andrew A. Moshfeghi
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 2191 - 2200
  • [2] Factors Associated with Diabetic Macular Edema Development in Patients with Proliferative Diabetic Retinopathy
    O'Fee, John
    Juliano, Joseph
    Moshfeghi, Andrew A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [3] Patients Lost to Follow Up with Proliferative Diabetic Retinopathy & Diabetic Macular Edema
    Sami, Mohammed Abdul
    Bomdica, Prithvi
    Chaturvedi, Vivek
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [4] Novel Treatments for Diabetic Macular Edema and Proliferative Diabetic Retinopathy
    Nhon T. Le
    Zachary A. Kroeger
    Weijie Violet Lin
    Arshad M. Khanani
    Christina Y. Weng
    Current Diabetes Reports, 2021, 21
  • [5] Novel Treatments for Diabetic Macular Edema and Proliferative Diabetic Retinopathy
    Le, Nhon T.
    Kroeger, Zachary A.
    Lin, Weijie Violet
    Khanani, Arshad M.
    Weng, Christina Y.
    CURRENT DIABETES REPORTS, 2021, 21 (10)
  • [6] Risk Factors for Proliferative Diabetic Retinopathy and Diabetic Macular Edema in the South Indian Population
    Rizza, A. N.
    Susarla, Gayatri
    Khan, Rehana
    Wang, Victoria
    Brustoski, Kim
    Sarangapani, Sripriya
    Khetan, Vikas
    Raman, Rajiv
    Igo, Robert
    Iyengar, Sudha K.
    Sinnakaruppan, Mathavan
    Sobrin, Lucia
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [7] The presence of diabetic macular edema in patients with new onset vitreous hemorrhage associated with proliferative diabetic retinopathy
    Brown, Jeremiah
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [8] Identification of Key Vitreous Biomarkers in Diabetic Macular Edema Associated with Proliferative Diabetic Retinopathy
    Teague, Gianna C.
    Nandakumar, Namrata
    Lopez, Francisco J.
    Lashkari, Kameran
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [9] Loss to Follow-Up in Patients With Proliferative Diabetic Retinopathy or Diabetic Macular Edema
    Huang, Ryan S.
    Naidu, Sumana C.
    Mihalache, Andrew
    Popovic, Marko M.
    Kertes, Peter J.
    Sarraf, David
    Sadda, SriniVas R.
    Muni, Rajeev H.
    Kohly, Radha P.
    JAMA NETWORK OPEN, 2024, 7 (12)
  • [10] Pegaptanib Sodium for the Treatment of Proliferative Diabetic Retinopathy and Diabetic Macular Edema
    Giuliari, Gian P.
    Guel, David A.
    Gonzalez, Victor H.
    CURRENT DIABETES REVIEWS, 2009, 5 (01) : 33 - 38